Nighttime Feeding and Morning Endurance Performance
Effect of Nighttime Feeding on Morning Performance in Female Endurance Athletes
Sponsor study identifier
interventional
12
1 country
1
Study Start
June 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2015
Actual (reported)Study Completion
April 2015
Actual (reported)The purpose of this study is to investigate the influence of a nighttime feeding on next morning running performance, hydration status, and exercise metabolism in female endurance athletes. Specifically, the effect of a chocolate milk beverage will be examined versus a non-nutritive, flavor-matched placebo. The investigators hypothesize that the nighttime consumption of chocolate milk, a whole food complex, will result in improved next morning running performance versus placebo. Secondarily, the investigators hypothesize that any potential positive performance outcomes from the chocolate milk treatment may be due to an enhanced pre-exercise hydration status or improved exercise metabolism.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2014
Actual (reported)June 2014
Date type not reportedThis date has not been verified as actual or estimated.
June 11, 2014
Actual (reported)April 2015
Actual (reported)April 2015
Actual (reported)March 13, 2017
Actual (reported)Running Performance
10K time trial on a treadmill
24 hours
Urine Specific Gravity
24 hours
Urine Volume
24 hour
Exercise Metabolism
24 hours
In this arm, subjects receive chocolate milk
In this arm, subjects receive a flavor-matched placebo
12 oz, 7-8 hours prior to exercise trial (night before)
12 oz, non-caloric flavor-matched placebo
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Florida State University
Tallahassee, Florida, 32306, United States
Michael J Ormsbee, PhD
Florida State University
12 participants (actual enrollment reported by the registry).
First Submitted
April 1, 2014
First Posted
June 11, 2014
Study Start
June 2014
Date type not reportedThis date has not been verified as actual or estimated.
Minocycline Treatment in Acute Hemorrhagic Stroke
Contact the study team to confirm eligibility.
Primary Completion
April 2015
Actual (reported)Study Completion
April 2015
Actual (reported)Last Updated
March 13, 2017
Results First Posted
March 13, 2017
Record last verified: 2017-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: